X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4482) 4482
Book Review (1211) 1211
Publication (190) 190
Book Chapter (51) 51
Conference Proceeding (22) 22
Magazine Article (11) 11
Dissertation (4) 4
Book / eBook (1) 1
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3219) 3219
index medicus (3179) 3179
vitamin k - antagonists & inhibitors (2552) 2552
anticoagulants - therapeutic use (1498) 1498
warfarin (1498) 1498
female (1349) 1349
male (1333) 1333
anticoagulants (1175) 1175
anticoagulants - adverse effects (1120) 1120
aged (1106) 1106
atrial fibrillation (1023) 1023
anticoagulants - administration & dosage (943) 943
middle aged (879) 879
hematology (836) 836
administration, oral (833) 833
vitamin k antagonists (809) 809
risk factors (772) 772
peripheral vascular disease (717) 717
dabigatran (675) 675
stroke (655) 655
hemorrhage - chemically induced (650) 650
atrial fibrillation - drug therapy (639) 639
vitamin-k antagonists (639) 639
cardiac & cardiovascular systems (614) 614
anticoagulation (613) 613
rivaroxaban (595) 595
international normalized ratio (570) 570
aged, 80 and over (561) 561
venous thromboembolism (556) 556
thromboembolism (538) 538
atrial-fibrillation (506) 506
treatment outcome (506) 506
risk (501) 501
management (495) 495
stroke - prevention & control (488) 488
adult (476) 476
atrial fibrillation - complications (469) 469
vitamin k antagonist (458) 458
therapy (439) 439
medicine, general & internal (435) 435
prevention (411) 411
thromboembolism - prevention & control (372) 372
abridged index medicus (363) 363
apixaban (350) 350
warfarin - therapeutic use (347) 347
pharmacology & pharmacy (346) 346
bleeding (325) 325
vitamin k (325) 325
oral anticoagulants (324) 324
stroke prevention (322) 322
thrombosis (318) 318
warfarin - adverse effects (311) 311
retrospective studies (303) 303
oral anticoagulation (294) 294
safety (294) 294
antithrombotic therapy (292) 292
time factors (283) 283
hemorrhage (282) 282
care and treatment (279) 279
molecular-weight heparin (271) 271
stroke - etiology (269) 269
blood coagulation - drug effects (268) 268
medicine & public health (268) 268
anticoagulants - pharmacology (264) 264
warfarin - administration & dosage (264) 264
heparin - therapeutic use (263) 263
risk assessment (260) 260
analysis (258) 258
deep-vein thrombosis (251) 251
prospective studies (246) 246
fibrinolytic agents - therapeutic use (243) 243
venous thromboembolism - drug therapy (242) 242
animals (236) 236
drug therapy (235) 235
randomized controlled trials as topic (233) 233
heparin, low-molecular-weight - therapeutic use (221) 221
internal medicine (218) 218
mortality (218) 218
direct oral anticoagulants (215) 215
patients (212) 212
prothrombin complex concentrate (212) 212
cardiology (210) 210
aspirin (206) 206
cardiac arrhythmia (202) 202
heparin (199) 199
metaanalysis (196) 196
oral anticoagulant-therapy (194) 194
venous thrombosis - drug therapy (193) 193
non-vitamin k antagonist oral anticoagulants (190) 190
factor xa inhibitors (186) 186
follow-up studies (185) 185
pulmonary embolism (185) 185
efficacy (184) 184
recurrence (184) 184
thrombin (183) 183
hemorrhage - prevention & control (182) 182
drug interactions (181) 181
dabigatran etexilate (171) 171
health aspects (169) 169
dose-response relationship, drug (168) 168
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3418) 3418
French (565) 565
German (272) 272
Spanish (98) 98
Russian (36) 36
Japanese (28) 28
Italian (24) 24
Danish (23) 23
Portuguese (20) 20
Hungarian (19) 19
Polish (17) 17
Dutch (12) 12
Romanian (6) 6
Chinese (4) 4
Korean (4) 4
Swedish (4) 4
Norwegian (3) 3
Croatian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Revista Espanola de Cardiologia, ISSN 0300-8932, 09/2015, Volume 68, Issue 9, pp. 761 - 768
Introduction and objectives: To study the prevalence of poorly controlled vitamin K antagonist anticoagulation in Spain in patients with nonvalvular atrial... 
Rosendaal method | Nonvalvular atrial fibrillation | Vitamin K antagonists | Oral anticoagulants
Journal Article
Journal Article
Revue de Medecine Interne, ISSN 0248-8663, 07/2018, Volume 39, Issue 7, pp. 546 - 550
Background: Adverse events related to vitamin K antagonists (VKA) represent a major public health problem. Informative tools and educative program contributes... 
Patient education | Vitamin K antagonists | Needs assessment
Journal Article